The city of Durham, North Carolina, currently has 14 active clinical trials seeking participants for COVID19 research studies.
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
NCT03808922
Recruiting
This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection. It also contains a sub-study to enroll patients with severe COVID-19.
Gender:
All
Ages:
All
Trial Updated:
07/19/2023
Locations: Duke University, Durham, North Carolina
Conditions: Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised, COVID-19
Register for Updates
Duke COVID-19 Shared Data and Specimen Repository
NCT04368234
Recruiting
The purpose of this data repository is to provide a secure and centralized storage location and resource for the collection of essential data and medical specimens, across COVID-19 related protocols at Duke.
Gender:
All
Ages:
All
Trial Updated:
05/10/2023
Locations: Duke University Medical Center, Durham, North Carolina
Conditions: COVID-19
Register for Updates